National Coverage Determination (NCD)

Anti-Inhibitor Coagulant Complex (AICC)

110.3

Expand All | Collapse All

Tracking Information

Publication Number
100-3
Manual Section Number
110.3
Manual Section Title
Anti-Inhibitor Coagulant Complex (AICC)
Version Number
1
Effective Date of this Version
This is a longstanding national coverage determination. The effective date of this version has not been posted.

Description Information

Benefit Category
Blood Clotting Factors for Hemophilia Patients


Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Indications and Limitations of Coverage

Anti-inhibitor coagulant complex, AICC, is a drug used to treat hemophilia in patients with factor VIII inhibitor antibodies. AICC has been shown to be safe and effective and has Medicare coverage when furnished to patients with hemophilia A and inhibitor antibodies to factor VIII who have major bleeding episodes and who fail to respond to other, less expensive therapies.

Additional Information

Other Versions
Title Version Effective Between
Anti-Inhibitor Coagulant Complex (AICC) 1 01/01/1966 - N/A You are here